Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG and Pegylated GCSF in Established Type 1 Diabetes
NCT01106157Phase 2Completed
- Sponsor
- University of Florida
- Start
- Apr 2010
- Primary completion
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit, pegfilgrastim in type 1 diabetes mellitus (T1D), sponsored by University of Florida. Started Apr 2010; status: completed.
02
Drugs
antithymocyte globulin rabbitpegfilgrastim
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01106157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01106157.